The ECTRIMS Podcast
The European Committee for Treatment and Research in Multiple Sclerosis
The world is better when its people are connected. The ECTRIMS Podcast aims to be a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.
Categories: Science & Medicine
Listen to the last episode:
If you talk to someone living with MS about their journey, one of the first things they will tell you is that they knew something was wrong long before they received their diagnosis. While this anecdotal evidence has been commonly discussed, it was only relatively recently that the research world has started to investigate this concept. Through this work, the idea of an MS prodrome has been studied, with potential implications for early diagnosis and treatment. Host Brett Drummond of MSTranslate speaks with Prof. Helen Tremlett of the University of British Columbia, a leading expert in recognising and investigating the MS prodrome.
Previous episodes
-
48 - MS Prodrome: Implications and Future Research DirectionsThu, 07 Nov 2024 - 0h
-
47 - Episode 37: Future MS TherapeuticsThu, 24 Oct 2024 - 0h
-
46 - MS Nurses at ECTRIMS 2024Thu, 10 Oct 2024 - 0h
-
45 - Patient Community Day Highlights of ECTRIMS 2024: Part IIWed, 09 Oct 2024 - 0h
-
44 - Patient Community Day Highlights of ECTRIMS 2024: Part IThu, 03 Oct 2024 - 0h
-
43 - Episode 36: Advancing MS Knowledge through the ECTRIMS FellowshipThu, 26 Sep 2024 - 0h
-
42 - Day 3 Highlights of ECTRIMS 2024Fri, 20 Sep 2024 - 0h
-
41 - Day 2 Highlights of ECTRIMS 2024Thu, 19 Sep 2024 - 0h
-
40 - Day 1 Highlights of ECTRIMS 2024Wed, 18 Sep 2024 - 0h
-
39 - Pre-Day Highlights of ECTRIMS 2024Tue, 17 Sep 2024 - 0h
-
38 - Episode 35: NMOSD and MOGAD Part IITue, 10 Sep 2024 - 0h
-
37 - Episode 35: NMOSD and MOGAD Part ITue, 10 Sep 2024 - 0h
-
36 - ECTRIMS-EAN Vaccination Consensus Statement (eanCast)Wed, 04 Sep 2024 - 0h
-
35 - Environmental, Genetic, and Epigenetic Risk Factors in MSThu, 15 Aug 2024 - 0h
-
34 - Myelin plasticity and repairTue, 23 Jul 2024 - 0h
-
33 - Lifestyle Modifications in MSTue, 25 Jun 2024 - 0h
-
32 - The Impact of Ageing on MSWed, 05 Jun 2024 - 0h
-
31 - Artificial Intelligence in MS ResearchThu, 16 May 2024 - 0h
-
30 - Prioritising Women's Health Topics in MS ResearchSat, 20 Apr 2024 - 0h
-
29 - Spotlight on Young MS ResearchersFri, 29 Mar 2024 - 0h
-
28 - MS in the Black CommunityThu, 07 Mar 2024 - 0h
-
27 - Efforts Towards a Better MS Diagnostic CriteriaTue, 13 Feb 2024 - 0h
-
26 - Factoring in Female Health in the MS JourneyWed, 31 Jan 2024 - 0h
-
25 - The Importance of Patient Community DayThu, 11 Jan 2024 - 0h
-
24 - Genetics and MS SeverityFri, 15 Dec 2023 - 0h
-
23 - Defining MS Subtypes in Clinical PracticeThu, 30 Nov 2023 - 0h
-
22 - The Changing Role of MS NursesWed, 15 Nov 2023 - 0h
-
21 - Discontinuing DMTs in Patients with Stable Relapsing-remitting MS: When and How?Fri, 10 Nov 2023 - 0h
-
20 - Day Three Highlights of MSMilan2023Fri, 13 Oct 2023 - 0h
-
19 - Day Two Highlights of MSMilan2023Thu, 12 Oct 2023 - 0h
-
18 - Day One Highlights of MSMilan2023Wed, 11 Oct 2023 - 0h
-
17 - Behind the landmark WHO decision on essential medicines for MSThu, 21 Sep 2023 - 0h
-
16 - Women with MSThu, 10 Aug 2023 - 0h
-
15 - Utilising Global Data Registries for MS ResearchThu, 29 Jun 2023 - 0h
-
14 - Epstein-Barr Virus and Multiple SclerosisWed, 24 May 2023 - 0h
-
13 - Access For All: Adding MS DMTs to the WHO Essential Medicines ListWed, 12 Apr 2023 - 0h
-
12 - Using Real-World Studies to Compare DMTs in MSWed, 29 Mar 2023 - 0h
-
11 - Remyelination in MS: a New Clinical TrialMon, 06 Mar 2023 - 0h
-
10 - Stem Cell Research in Multiple SclerosisTue, 24 Jan 2023 - 0h
-
9 - ECTRIMS 2022 For People with MS: Part 3Wed, 28 Dec 2022 - 0h
-
8 - ECTRIMS 2022 For People with MS: Part 2Wed, 21 Dec 2022 - 0h
-
7 - ECTRIMS 2022 For People with MS: Part 1Sat, 17 Dec 2022 - 0h
-
6 - Rethinking how different types of MS are describedSat, 19 Nov 2022 - 0h
-
5 - The role of the MS nurse & the need for more globally: an ECTRIMS 2022 recapWed, 16 Nov 2022 - 0h
-
4 - ECTRIMS 2022 Wrap-upSat, 29 Oct 2022 - 0h
-
3 - Day Two Highlights of ECTRIMS 2022Fri, 28 Oct 2022 - 0h
-
2 - Day One Highlights of ECTRIMS 2022Thu, 27 Oct 2022 - 0h
-
1 - NEW! The ECTRIMS PodcastMon, 17 Oct 2022 - 0h
